SUBSCRIBERS
Best World to invest in A*Star startup with an eye on stem cell-based products
Published Mon, Jan 14, 2019 · 09:50 PM
Singapore
BEST World International is investing in A*Star spinoff Celligenics as it seeks to leverage on synergies with its own business in the health and wellness sector.
In a filing with the Singapore Exchange on Monday, it said that it had entered into a share subscription agreement (SSA) with Celligenics.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results
Porsche posts Q1 profit drop on ramp-up costs
IBM plots US$730 million expansion of Canadian semiconductor site
Seatrium unit to fully redeem S$500 million worth of floating-rate bonds early
Yeo Guat Kwang, John Chen retiring from corporate boards